The anniversary will be celebrated during ICMRA’s annual summit and Plenary in Melbourne on 13-16 November, hosted by the Therapeutic Goods Administration (TGA) of Australia. ICMRA members will exchange views and discuss topics such as the use of artificial intelligence and machine learning in medicine regulation, evolution of clinical trials and advanced medical products based on genes, cells or tissue engineering.

In the past decade, ICMRA has made significant progress in a range of areas which are at the heart of the work of many regulators worldwide. Significant milestones include activities supporting the fight against antimicrobial resistance and the management of medicines shortages, but also topics such as clinical trials, pharmacovigilance, regulatory convergence and reliance, innovation, real-world evidence and alignment in the global COVID-19 response.

ICMRA’s major achievement is the leadership provided by its members working together during the COVID-19 pandemic….